 |
市场调查报告书
商品编码
1490005
细胞疗法製造市场：按治疗类型、按技术类型、按製造目的、按应用、按地区Cell Therapy Manufacturing Market, By Therapy Type, By Technology Type, By Manufacturing Purpose, By Application, By Geography |
||||||
价格
简介目录
2024年全球细胞疗法製造市场价值为49.1亿美元，预计到2031年将达到129.6亿美元，2024年至2031年的复合年增长率为14.9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 49.1亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 2024-2031 年预测期间的复合年增长率： | 14.90% | 2031 年金额预测 | 129.6亿美元 |
图：2024 年按地区分類的细胞疗法製造市场份额 (%)
近年来，由于心臟疾病等慢性疾病的盛行率不断上升，全球细胞疗法製造市场出现了显着增长。与传统药物相比，细胞疗法是针对多种病症更有效的治疗选择。细胞治疗製造技术的进步和政府对细胞研究的支持，特别是在美国和欧洲，预计将在预测期内推动市场成长。然而，与细胞疗法开发和製造相关的高成本可能会阻碍市场成长。
市场动态：
全球细胞疗法製造市场的成长是由心臟疾病等慢性疾病日益普及所推动的。细胞疗法製造技术的进步实现了高效、大规模生产，这是市场成长的驱动力。主要市场的各国政府正在透过财政支持和监管指南来支持细胞研究，这为市场参与者提供了机会。然而，细胞疗法从实验室开发到商业化的高成本可能会阻碍市场成长。参与企业需要巨额资本投资，这阻碍了市场的成长。缺乏熟练的细胞处理专家也阻碍了市场的成长。公司之间持续的併购在不久的将来提供了潜在的成长机会。
本研究的主要特点
- 该报告对全球细胞疗法製造市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
- 根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球细胞疗法製造市场的主要企业进行了分析。
- 主要企业包括WuXi AppTec, Inc.Lonza、Merck KGaA、Takara Bio Inc.、Sumitomo Dainippon Pharma Co., LTD.、Fujifilm Holdings Corporation、Thermo Fisher Scientific, Inc.、Astellas Pharma Inc.、OXGENE、Cytiva、Exothera、Charles River Laboratories、Cell Therapies Pty Ltd、Bio-Techne 和Catalent, Inc.
- 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 全球细胞疗法製造市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以透过用于分析全球细胞治疗製造市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球细胞治疗製造市场 - 冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球细胞疗法製造市场，依治疗类型，2019-2031
- 同种异体细胞疗法
- 自体细胞疗法
第六章全球细胞疗法製造市场，依技术类型，2019-2031
- 体细胞技术
- 细胞永生化技术
- 病毒载体技术
- 基因组编辑技术
- 细胞可塑性技术
- 3D技术
第七章全球细胞疗法製造市场，依製造目的，2019-2031
- 临床
- 商业的
- 临床前
第八章全球细胞疗法製造市场，依应用分类，2019-2031
- 肌肉骨骼
- 心血管
- 胃
- 神经学的
- 肿瘤学
- 皮肤科
- 其他的
第9章全球细胞疗法製造市场，按地区，2019-2031
第10章竞争格局
- 公司简介
- WuXi AppTec, Inc.
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc
第十一章分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map
第十二章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI1728
Global cell therapy manufacturing market is estimated to be valued at USD 4.91 Bn in 2024 and is expected to reach USD 12.96 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 4.91 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 14.90% | 2031 Value Projection: | US$ 12.96 Bn |
Figure. Cell Therapy Manufacturing Market Share (%), By Region, 2024
Global cell therapy manufacturing market has been witnessing significant growth in the recent years, owing to growing prevalence of chronic diseases such as cancer and cardiac disorders. Cell therapies are more effective treatment options for various conditions as compared to traditional drugs. The advancement in cell therapy manufacturing technology and government support for cell-based research especially in the U.S. and Europe are projected to drive the market growth during the forecast period. However, high costs associated with cell therapy development and manufacturing can hamper the market growth.
Market Dynamics:
Global cell therapy manufacturing market growth is driven by growing prevalence of chronic diseases such as cancer and cardiac disorders. Advancements in cell therapy manufacturing technologies enable efficient and large-scale production, and this drives the market growth. Various governments across major markets are supporting cell-based research through funding and regulatory guidelines, and this offers opportunities for market players. However, high costs associated with cell therapy development from laboratory to commercialization can hamper the growth of market. Market players require huge capital investments, and this hampers the market growth. Lack of skilled professionals for cell processing also hampers the market growth. Ongoing mergers and acquisitions among players provides potential growth opportunities in the near future.
Key Features of the Study:
- This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cell therapy manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., Healios Ltd. , Lonza, Merck KGaA, Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD., Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc., OXGENE, Cytiva, Exothera, Charles River Laboratories, Cell Therapies Pty Ltd, Bio-Techne, Catalent, Inc
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global cell therapy manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market.
Detailed Segmentation-
- By Therapy Type:
- Allogeneic Cell Therapy
- Autologous Cell Therapy
- By Technology Type:
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- 3D Technology
- By Manufacturing Purpose:
- Clinical
- Commercial
- Pre-clinical
- By Application:
- Musculoskeletal
- Cardiovascular
- Gastrointestinal
- Neurological
- Oncology
- Dermatology
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- WuXi AppTec, Inc.
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Technology Type
- Market Snapshot, By Manufacturing Purpose
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cell Therapy Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Cell Therapy Manufacturing Market, By Therapy Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Allogeneic Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Autologous Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Cell Therapy Manufacturing Market, By Technology Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Somatic Cell Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cell Immortalization Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Viral Vector Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Genome Editing Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cell Plasticity Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- 3D Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Cell Therapy Manufacturing Market, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Commercial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pre-clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Cell Therapy Manufacturing Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Musculoskeletal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gastrointestinal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Dermatology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Cell Therapy Manufacturing Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- WuXi AppTec, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lineage Cell Therapeutics, Inc.
- Healios Ltd.
- Lonza
- Merck KGaA
- Takara Bio Inc.
- Sumitomo Dainippon Pharma Co., LTD.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific, Inc.
- Astellas Pharma Inc.
- OXGENE
- Cytiva
- Exothera
- Charles River Laboratories
- Cell Therapies Pty Ltd
- Bio-Techne
- Catalent, Inc
- WuXi AppTec, Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
2024-2032 年日本细胞和基因治疗市场报告（按治疗类型、适应症、交付模式、最终用户和地区划分）
2024-2032 年日本细胞治疗市场报告（按细胞类型、治疗类型、治疗领域、最终用户和地区划分）
2024-2032 年自然杀手细胞治疗市场报告（按治疗方法、应用、最终用户和地区）
自动化和封闭式细胞疗法的全球市场
细胞治疗生物製造：全球市场
自体细胞治疗市场 - 全球产业规模、份额、趋势、机会和预测，按来源、应用、最终用户、地区和竞争细分，2019-2029F
个人化细胞治疗市场：依细胞类型、依治疗领域、依最终使用者、按地区
自体细胞疗法市场规模、份额和趋势分析报告：2024-2030 年按应用、来源、最终用途、地区和细分市场进行的预测
全球细胞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测
全球自然杀手细胞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测
▼